DK158138C - Fremgangsmaade til fremstilling af immunoglobulin-igg-holdig maelk eller herudfra afledt produkt til behandling af rheumatoid arthritis - Google Patents

Fremgangsmaade til fremstilling af immunoglobulin-igg-holdig maelk eller herudfra afledt produkt til behandling af rheumatoid arthritis

Info

Publication number
DK158138C
DK158138C DK049479A DK49479A DK158138C DK 158138 C DK158138 C DK 158138C DK 049479 A DK049479 A DK 049479A DK 49479 A DK49479 A DK 49479A DK 158138 C DK158138 C DK 158138C
Authority
DK
Denmark
Prior art keywords
igg
rheumatoid arthritis
derived product
containing milk
treat rheumatoid
Prior art date
Application number
DK049479A
Other languages
English (en)
Other versions
DK49479A (da
DK158138B (da
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of DK49479A publication Critical patent/DK49479A/da
Publication of DK158138B publication Critical patent/DK158138B/da
Application granted granted Critical
Publication of DK158138C publication Critical patent/DK158138C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK049479A 1978-02-06 1979-02-06 Fremgangsmaade til fremstilling af immunoglobulin-igg-holdig maelk eller herudfra afledt produkt til behandling af rheumatoid arthritis DK158138C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06
US87514078 1978-02-06

Publications (3)

Publication Number Publication Date
DK49479A DK49479A (da) 1979-08-07
DK158138B DK158138B (da) 1990-04-02
DK158138C true DK158138C (da) 1990-08-27

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK049479A DK158138C (da) 1978-02-06 1979-02-06 Fremgangsmaade til fremstilling af immunoglobulin-igg-holdig maelk eller herudfra afledt produkt til behandling af rheumatoid arthritis

Country Status (10)

Country Link
JP (1) JPS54113425A (da)
CH (1) CH651210A5 (da)
DE (1) DE2904044C2 (da)
DK (1) DK158138C (da)
FR (1) FR2416015A1 (da)
GB (1) GB2013691B (da)
HK (1) HK30283A (da)
IT (1) IT1116524B (da)
NL (1) NL7900766A (da)
SE (1) SE448344B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
WO1982002818A1 (en) * 1981-02-26 1982-09-02 Gani Mohamed Mutwahar A process and apparatus for the recovery of immunoglobulins
ATE16349T1 (de) * 1981-04-28 1985-11-15 Stolle Res & Dev Verfahren zur herstellung einer entzuendungshemmenden rindermilch.
JP2561234B2 (ja) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション 抗炎症剤
JPS58154513A (ja) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho 予防及び治療薬
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
ATE39842T1 (de) * 1983-06-07 1989-01-15 Stolle Res & Dev Desodorant das bakterielle antikoerper enthaelt.
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
DE3785033T2 (de) * 1987-07-21 1993-10-07 Stolle Res & Dev Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung.
JP2664906B2 (ja) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション 改良された哺乳類の免疫法
WO2000062806A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
WO2002026258A2 (en) * 2000-09-28 2002-04-04 Research Corporation Technologies, Inc. Treatment of immune-mediated diseases by oral administration of plasma fractions
BR0206870A (pt) * 2001-01-30 2005-04-26 Lauridsen Group Inc Método de modulação de resposta imune de um animal, e, suplemento dietético
CA2437099A1 (en) * 2001-01-30 2002-10-10 The Lauridsen Group, Incorporated Methods and compositions for treatment of immune dysfunction disorders
JP4960632B2 (ja) * 2006-01-10 2012-06-27 学校法人北里研究所 免疫ミルク組成物を有効成分とする単純ヘルペスウイルス感染症治療予防用組成物
JP5361132B2 (ja) * 2006-03-10 2013-12-04 国立大学法人信州大学 免疫グロブリンｇを含有する経口用免疫調節剤、その製造方法及び経口用免疫調節剤を配合してなる飲食品
JP2008179572A (ja) * 2007-01-25 2008-08-07 Shinshu Univ 免疫グロブリンＦｃフラグメントレセプタータンパク及び／又は免疫グロブリンＦｃフラグメントレセプター様タンパク産生抑制剤及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488013A (de) * 1965-10-24 1970-03-31 Immune Milk Company Of America Verfahren zur Herstellung von Antitoxinen
DE1617769A1 (de) * 1967-06-10 1971-04-01 Rehm Eberhard Verfahren zur Gewinnung von spezifischen Antikoerper enthaltender Milch und daraus hergestellter Praeparate
JPS5136326A (ja) * 1974-09-24 1976-03-27 Komatsu Seiren Co Seikeigorufubooru
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
DK49479A (da) 1979-08-07
GB2013691A (en) 1979-08-15
JPH0160455B2 (da) 1989-12-22
FR2416015A1 (fr) 1979-08-31
GB2013691B (en) 1982-08-18
JPS54113425A (en) 1979-09-05
SE448344B (sv) 1987-02-16
SE7900798L (sv) 1979-08-07
DE2904044C2 (de) 1986-02-06
DK158138B (da) 1990-04-02
IT7947888A0 (it) 1979-02-05
CH651210A5 (de) 1985-09-13
FR2416015B1 (da) 1983-06-17
HK30283A (en) 1983-09-02
DE2904044A1 (de) 1979-08-30
IT1116524B (it) 1986-02-10
NL7900766A (nl) 1979-08-08

Similar Documents

Publication Publication Date Title
DK158138C (da) Fremgangsmaade til fremstilling af immunoglobulin-igg-holdig maelk eller herudfra afledt produkt til behandling af rheumatoid arthritis
RO76889A (ro) Procedeu de preparare a unor 8-metoximetilergoline sau 8-metilmercaptometilergoline
NL7900020A (nl) Vloeibaar rookconcentraat en werkwijze ter bereiding daarvan.
DK552479A (da) Fremgangsmaade til oegning af vegetabilske proteinprodukters vandoploeselighed
NL7900211A (nl) Reinigingsprodukt en werkwijze ter bereiding daarvan.
DK146481C (da) Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
NL7900210A (nl) Reinigingsprodukt en werkwijze ter bereiding daarvan.
DK146942C (da) Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
BE875089A (fr) Procede de preparation de tetrahydrobenzoxocines et de cishexahydrodibenzopyranones
DK156253C (da) Fremgangsmaade til fremstilling af pyruvatoxidase
DK89279A (da) Fremgangsmaade til fremstilling af polymermodificerede bitumenprodukter
NL7901746A (nl) Werkwijze ter bereiding van kaassubstituten alsmede als zodanig verkregen produkten.
DK366379A (da) Fremgangsmaade til fremstilling af alkyl-eller arylthiomethylphenoler
IT1116535B (it) Procedimento ed apparecchio di riciclo degli effluenti di impianti per la fabbricazione di prodotti di cemento-amianto
DK152752C (da) Fremgangsmaade til fremstilling af l-sulpirid
DK344679A (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
IT7927903A0 (it) Derivati dell'acido 1,3,4-tiadiazol-2-carbossilico, procedimento di sintesi di questi composti e mezzi funghicidi e nematicidi che li contengono.
BE879537A (fr) Procede de synthese de ceto-acides ou ceto-esters
DK36379A (da) Fremgangsmaade til fremstilling af n-ethylethylendiamin
IT7947685A0 (it) Procedimento per la produzione di 2-pirrolidone e prodotto ottenuto
ATA321978A (de) Verfahren zur zubereitung von knoedeln
BE873355A (fr) Nouveaux revetements pour produits polyolefiniques et produits recouverts par ces revetements
NL7806402A (nl) Werkwijze voor het concentreren van macromoleculaire stoffen en hun monomere of oligomere eenheden.
JPS54111577A (en) Method of forming frp product
RO78606A (ro) Procedeu pentru prepararea heparinei

Legal Events

Date Code Title Description
PUP Patent expired